About Canngea
Canngea is a company based in Sydney (Australia) founded in 2017 by Colin Sergay and Martin Bryden. It operates as a B2B. The company has 653 employees as of March 31, 2023. Canngea offers products and services including Pharmacy Ordering Portal and Prescribers Portal. Canngea operates in a competitive market with competitors including Cannaponics, THC Global Group, ESense-Lab, Elite Cannabinoids and SproutAI, among others.
- Headquarter Sydney, Australia
- Employees 653 as on 31 Mar, 2023
- Founders Colin Sergay, Martin Bryden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Jurisdiction Shaikpet, Telangana, India
-
Annual Revenue
$41.42 M (USD)59.42as on Mar 31, 2023
-
Net Profit
$6.79 M (USD)281.61as on Mar 31, 2023
-
EBITDA
$10.42 M (USD)246.16as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
653
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Canngea
Canngea offers a comprehensive portfolio of products and services, including Pharmacy Ordering Portal and Prescribers Portal.
Platform for pharmacies to order medicinal cannabis products compliantly.
Service providing guidelines and details on medicinal cannabis for prescribers.
People of Canngea
Unlock access to complete
Unlock access to complete
Funding Insights of Canngea
Investments & Acquisitions by Canngea
Financial Statements - Canngea
Canngea Comparisons
Competitors of Canngea
Canngea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cannaponics, THC Global Group, ESense-Lab, Elite Cannabinoids and SproutAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical cannabis products are cultivated and produced in Australia.
|
|
| domain | founded_year | HQ Location |
Medicinal cannabis products are cultivated, processed, and supplied vertically.
|
|
| domain | founded_year | HQ Location |
Terpene-based cannabis products are developed using genetic and analytical profiling.
|
|
| domain | founded_year | HQ Location |
Cannabis crops are cultivated and processed for medicinal cannabinoid supply.
|
|
| domain | founded_year | HQ Location |
Aeroponic vertical farms for cannabis cultivation are manufactured.
|
|
| domain | founded_year | HQ Location |
Vertically integrated B2B enterprise for medicinal plant cultivation and distribution.
|
Latest news on Canngea
Frequently Asked Questions about Canngea
Canngea was founded in 2017.
Canngea is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
As of Mar 31, 2023, the latest employee count at Canngea is 653.
Annual revenue of Canngea is $41.42M as on Mar 31, 2023.
Canngea operates as a trusted pharmaceutical wholesaler specializing in medicinal cannabis products in Australia. They partner with pharmacies to ensure reliable and compliant supply through approved regulatory pathways. The company supports healthcare professionals with information on prescribing guidelines and requirements. Services include distribution, import, export, and supply chain management, all based in Brisbane, serving the medical community nationwide.
Canngea's top competitors include THC Global Group, ESense-Lab and Cannaponics.
Canngea offers Pharmacy Ordering Portal and Prescribers Portal.